article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

So that is a wide range of techniques to look at the protein-ligand interactions, all with the aim to guide the optimisation of our first screening hits to potent inhibitors that hopefully are cell-active at some point. 2011) D67, 386-394) using PDB ID 4GV1 which was published as part of Addie et al. Acta Cryst.

article thumbnail

How to Get Drugs Into the Brain

Drug Hunter

A) Progression of a Novartis HAT program from a screening hit to brain-penetrant leads. This program started from an HTS screen of 3M compounds, resulting in a singleton hit (Figure 17). He worked at the University of Kyoto in 2011 and at the University of Münster in 2013. Figure 18.

Drugs 206